Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Reviewed by Caitlin Clarke Fact checked by Vikki Velasquez The Dow Jones Industrial Average, also known as the Dow or DJIA, ...

The latest trading week ended on a very sour note, given that the average stock in the broad-based Russell 3000 index declined 1.2% on Friday, even as the Dow Jones Industrial Average managed to ...

UnitedHealth beat fourth-quarter earnings forecast, though revenue fell short and medical costs ran high, hitting the Dow Jones component.

Shares of Elevance Health jumped early Thursday in response to better-than-expected fourth- quarter results, and a generally optimistic outlook for the coming year. A week after UnitedHealth Group ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...